CoV-2 N (1-419), HEK

Coronavirus 2019 Nucleocapsid (1-419 a.a.), Recombinant, HEK
Cat. No.
BT1720
Source

HEK293 Cells.

Synonyms
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity

Protein is >95% pure as determined SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The HEK293 derived recombinant protein contains the Coronavirus 2019 CoV-2 Nucleocapsid, Wuhan-Hu-1 strain, amino acids 1-419 fused to His tag at C-terminal having a calculated Mw of 47.3 kDa and migrating between 60-65 due to glycosylation.

Product Specs

Introduction

The novel coronavirus responsible for causing viral pneumonia, officially named 2019-nCoV (later designated as SARS-CoV-2), was first identified in December 2019 in Wuhan, Hubei province, China. Its emergence was linked to a local seafood market.

Genetic analysis revealed that 2019-nCoV shared a high degree of similarity (87%) with SARS-CoV-2 strains detected in bats in Zhoushan, eastern China, in 2018. The virus utilizes a similar receptor-binding domain (RBD) structure as the 2018 SARS-CoV, despite some amino acid variations. This similarity allows 2019-nCoV to bind to the human ACE2 receptor (angiotensin-converting enzyme 2).

While bats are considered the likely natural reservoir of 2019-nCoV, an intermediate animal host, potentially present at the seafood market, is suspected to have played a role in its transmission to humans. Research suggests that 2019-nCoV may have arisen from a recombination event within its spike glycoprotein, involving a bat coronavirus and another unknown coronavirus.

Description

This recombinant protein is derived from HEK293 cells and encompasses amino acids 1 to 419 of the SARS-CoV-2 Nucleocapsid protein (Wuhan-Hu-1 strain). A C-terminal His tag is present for purification purposes. The calculated molecular weight is 47.3 kDa. However, due to glycosylation, the protein exhibits a migration pattern between 60-65 kDa on SDS-PAGE.

Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation

The CoV-2 Nucleocapsid protein is provided in a solution of 1x PBS (pH 7.4) containing 10% trehalose.

Stability

Lyophilized CoV-2 Nucleocapsid protein remains stable at room temperature for up to 3 weeks. However, for extended storage, it is recommended to store the desiccated protein below -18°C. After reconstitution, the protein can be stored at 4°C for 2-7 days. For long-term storage, aliquot and store below -18°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.

Solubility

To prepare a working stock solution, add deionized water to the lyophilized pellet to achieve a concentration of approximately 0.5 mg/ml. Allow the pellet to dissolve completely.

Purity

The purity of the protein is determined to be greater than 95% as assessed by SDS-PAGE analysis.

Source

HEK293 Cells.

Purification Method

Purified by Metal-Afinity chromatographic technique.

Product Science Overview

Introduction

The Coronavirus 2019 Nucleocapsid (N) protein, specifically the segment spanning amino acids 1-419, is a critical component of the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic. This protein is often produced recombinantly in human embryonic kidney (HEK) cells for research and diagnostic purposes. The N protein plays a pivotal role in the viral life cycle, including the packaging of viral RNA and the assembly of new virions .

Structure and Function

The N protein is an abundant RNA-binding protein that is essential for the encapsidation of the viral genome. It is composed of 419 amino acids and has a molecular weight of approximately 45.6 kDa . The protein is highly immunogenic, making it a valuable target for diagnostic assays and vaccine development . Structurally, the N protein contains multiple domains that facilitate its interaction with RNA and other viral components .

Role in the Viral Life Cycle

The N protein is involved in several critical stages of the SARS-CoV-2 life cycle. It assists in the packaging of the viral RNA genome into ribonucleoprotein complexes, which are then assembled into new virions . Additionally, the N protein plays a role in the regulation of viral RNA synthesis and the modulation of host cell responses . Its high abundance in virions and strong immunogenicity make it a key target for both diagnostic and therapeutic strategies .

Recombinant Production in HEK Cells

Recombinant production of the N protein in HEK cells is a common method used to obtain large quantities of the protein for research and diagnostic purposes. HEK cells are preferred due to their ability to perform post-translational modifications that are similar to those in human cells, ensuring that the recombinant protein closely resembles its native form . The recombinant N protein is often tagged with a His-tag to facilitate purification and detection .

Applications in Research and Diagnostics

The recombinant N protein is widely used in various research and diagnostic applications. Its strong immunogenicity makes it an ideal candidate for the development of serological assays to detect antibodies against SARS-CoV-2 in patient samples . Additionally, the N protein is used in studies aimed at understanding the molecular mechanisms of SARS-CoV-2 infection and the host immune response . It also serves as a potential target for the development of antiviral drugs and vaccines .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.